Reviewing Records of Advanced Endoscopic Removal of Rectal Tumors
Reviews past records of endoscopic and surgical tumor removal in adults with rectal tumors.
Key facts
- Who runs it
- Jagiellonian University
- Where
- Krakow, PolandSee the site
- Trial code
- Registry title
- Advanced Endoscopic Resections for Rectal Neoplasms
- Status
- Not yet recruiting
- People taking part
- 300 people, planned
- Started
- 1 Mar 2026
- Planned end
- 30 Apr 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Endoscopic submucosal dissection
- Endoscopic intramuscular dissection
- Record updated
- 18 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study looks at records of adults whose rectal tumors were removed by advanced endoscopic resection. It reviews past records only.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Rectal neoplasms (tumors) treated by advanced endoscopic resection
- Earlier treatment
- Must have been treated by advanced endoscopic resection
Main reasons for not taking part
- Hybrid resection was performed
- Full-thickness resection was performed
- Essential procedure or outcome data are missing
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients with rectal neoplasms treated by advanced endoscopic resection
Who cannot take part
- hybrid resection performed
- full-thickness resection performed
- essential procedural or outcome data were unavailable
Where in Poland
- Jagiellonian University in KrakowKrakow, PolandContact: Zofia Orzeszko, MDNo longer taking part
About the trial
What the trial wants to find out
This study evaluates how advanced endoscopic resection techniques affect treatment outcomes in adults with rectal cancer.
Read full original descriptionShow less
Rectal cancer has traditionally been treated with standard abdominal surgery. Newer endoscopic techniques allow removal of selected early tumors and may reduce treatment-related complications. However, their effectiveness and safety in tumors with deeper invasion are not yet fully established.
This multicenter retrospective observational study uses existing medical records from adults who underwent endoscopic or surgical resection of rectal tumors between 2015 and 2025. Researchers will analyze anonymized information on procedures performed and treatment outcomes to assess the safety and effectiveness of advanced endoscopic approaches.
The results of this study may help guide treatment selection and improve care for people with rectal cancer.
The 2 groups in the trial
- ESD
Patients who underwent endoscopic submucosal dissection for rectal neoplasm
Treatment: Endoscopic submucosal dissection
- EID
Patients who underwent endoscopic intermuscular dissection for rectal neoplasm
Treatment: Endoscopic intramuscular dissection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Adoption of Advanced Endoscopic Resection Methods in the Treatment of Rectal Neoplasms
- Plain-language title
- Reviewing Records of Advanced Endoscopic Removal of Rectal TumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 February 2026